Polish startup Aether Biomedical has landed a financing round led by the New York-based Story Ventures fund, as well as Sunfish Partners, Chiratae Ventures, Joyance Partners and business angels funds.
The funds raised will be used primarily for further technology development and expansion in the USA.
Aether Biomedical plans to allocate the acquired funds primarily to intensive research and development in the areas of artificial intelligence and robotics. In the coming months, the startup will continue the development of Zeus products, in particular its sensory feedback control system.
To this end, Aether Biomedical plans to enlarge its team, which currently has 25 people, including specialists in the field of robotics, machine learning, but also with experience in the prosthetic industry. By the end of the year, the company wants to employ another 15 people, engineers and developers, including biosignal processing specialists, who will contribute to the further development of the technology. The startup also plans to hire, among others, production managers and marketing specialists who will deal with product promotion.
“We founded Aether Biomedical to solve the biggest problems hampering rehabilitation and the development of assistive technologies. When creating and developing our Zeus upper limb prosthesis, we decided to start at the source of the problem and remove a key barrier: lack of device-user communication and outdated control methods. (…)”said co-founder and CEO of Aether Biomedical Dhruv Agrawal.